S2283 Risk of De Novo Gastroparesis in Non-Diabetic Patients With Obesity Taking Tirzepatide Versus Semaglutide: A Multi-Center Analysis.
American Journal of Gastroenterology | October 24, 2024 | Volume: 119 | Issue: 10S | Pages: S1636-S1636
10.14309/01.ajg.0001038500.33915.6f